(Q44222424)
Statements
Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study (English)
M Colozza
G Bisagni
A M Mosconi
C Boni
R Sabbatini
R Passalacqua
A Rosa Bian
C Rodinò
E Rondini
R Algeri
S Di Sarra
V De Angelis
G Cocconi
1 November 2002